MDEV vs PSIL: Holdings Overlap & Returns

Over the year to Nov 13, 2026, MDEV returned +8.8% to PSIL's +18.6%; 0% of their weight is in the same names.

Return gap
+9.8 pts1 year to Nov 13, 2026: PSIL ahead, total return
Fee gap
0.30 ptsA year: MDEV 0.70%, PSIL 1.00%, per filings dated Jul 29, 2026 and Oct 28, 2026
Overlap
0%Share of the two books held in common, holdings dated Nov 12, 2026 and Jun 30, 2026
Net flow
–Needs daily flows for both funds
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
MDEV and PSIL · 1 year

Growth of 100

MDEV +8.8%PSIL +18.6%
Growth of 100 in MDEV and PSIL over 1 year, Nov 13, 2025 to Nov 13, 2026, with distributions reinvested. MDEV ends at 108.8 (+8.8%), PSIL at 118.6 (+18.6%).

MDEV +8.8%, PSIL +18.6%: PSIL +9.8 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.

Share

Use this comparison

Alert

MDEV and PSIL flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag the order size

Cost to trade

Hypothetical. A $10,000 order in MDEV costs about $9.50 one way and $19.00 in and out, at a median spread of 0.19%. The 0.19% spread is MDEV’s 30-day median, from First Trust (fund page).

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in PSIL for 10 years at 1.00% a year costs about $1,620 in fees and lost growth; MDEV at 0.70% would cost $1,148. Assumes 6% a year before fees, a sample rate, not a forecast.

How each fund moved

MDEV · 1 year to Nov 13, 202652% of its weight is outside the S&P 500
52% of its weight is outside the S&P 50048% of MDEV's weight is in S&P 500 companies and 52% is outside the index. Holdings as of Nov 12, 2026.48%52%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 98% · top ten 23% of the fund · 50 holdings as published by its issuer for Nov 12, 2026 · Nasdaq-100: 6% in52% of its weight is outside the S&P 50048% of MDEV's weight is in S&P 500 companies and 52% is outside the index. Holdings as of Nov 12, 2026.48%52%in the S&P 500outside the S&P 500active share 98% · Nasdaq-100: 6% in

48% of MDEV's weight is in S&P 500 companies and 52% is outside the index. Holdings as of Nov 12, 2026.

PSIL · 1 year to Nov 13, 202692% of its weight is outside the S&P 500
92% of its weight is outside the S&P 5008% of PSIL's weight is in S&P 500 companies and 92% is outside the index. Holdings as of Jun 30, 2026.8%92%inof its weight outside the S&P 500active share 98% · top ten 69% of the fund · 27 holdings as filed for Jun 30, 2026 · Nasdaq-100: 0% in92% of its weight is outside the S&P 5008% of PSIL's weight is in S&P 500 companies and 92% is outside the index. Holdings as of Jun 30, 2026.8%92%8% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 98% · Nasdaq-100: 0% in

8% of PSIL's weight is in S&P 500 companies and 92% is outside the index. Holdings as of Jun 30, 2026.

Key numbers

MDEV in the S&P 500
47.8%
PSIL in the S&P 500
7.8%
MDEV total return, 1 year
+8.8%
PSIL total return, 1 year
+18.6%

MDEV costs 0.30 points a year less; their one-year returns differ by 9.8 points; PSIL is 12.4 times larger.

Pair scorecard

Open the table

Points (pts) are percentage points.

Total return, 1 year+8.8%+18.6%
Below its all-time high19.1%, high on Sep 7, 202178.3%, high on Sep 22, 2021
What it tracksTherapeutics and medical devicesTherapeutics and medical devices
Expense ratio0.70%1.00%
Net assets, as of Nov 12, 2026$3.4m$42m
Holdings in common0%

The numbers behind it

Net assets on Nov 12, 2026: $3.4m for First Trust Indxx Medical Devices ETF and $42m for AdvisorShares Psychedelics ETF.

Holdings in common uses holdings dated Jun 30, 2026 and Nov 12, 2026.

What they share

By the books each fund has filed, MDEV and PSIL hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Nov 12, 2026.

0half (50%)100%

half

0% in common

Only in MDEV

Show all 8 holdings
GE HealthCare Technologies Inc.2.35%
Edwards Lifesciences Corporation2.34%
Koninklijke Philips N.V.2.33%
Teleflex Incorporated2.31%
Straumann Holding AG (Registered)2.24%
Steris Plc2.23%
LivaNova Plc2.22%
Becton, Dickinson and Company2.21%

Only in PSIL

Show all 8 holdings
DEFINIUM THERAPEUTICS INC12.85%
COMPASS PATHWAYS PLC11.45%
ATAIBECKLEY INC10.47%
RELMADA THERAPEUTICS INC6.84%
NRX PHARMACEUTICALS INC6.07%
NEUROCRINE BIOSCIENCES INC4.38%
CYBIN INC4.36%
GH RESEARCH PLC4.31%

Side by side

Open the table
FundFirst Trust Indxx Medical Devices ETF · Holds 50 stocks in therapeutics and medical devices, 48% of its weight in S&P 500 companiesAdvisorShares Psychedelics ETF · Holds 27 stocks in therapeutics and medical devices, 8% of its weight in S&P 500 companies
IssuerFirst TrustAdvisorShares
ThemeTherapeutics and medical devicesTherapeutics and medical devices
In the S&P 50047.8%7.8%
Active share vs the S&P 50098.0%98.4%
In the Nasdaq-1006.1%0.0%
Holdings5027
Top ten, share of the fund22.6%69.2%
Expense ratio0.70%1.00%
Fee for the differing part0.71%1.02%
Total return, 1 year+8.8%+18.6%
vs its benchmarknot measurednot measured
Below its high−19.1%−78.3%
Net assets, as of Nov 12, 2026$3.4m$42m

As of Nov 13, 2026. Source: ETFIQ.

Window by window

Open the table
3 months+5.5%−23.9%
6 months+26.9%−3.7%
1 year+8.8%+18.6%
3 years+27.4%+62.8%
Since launch (Not the same days: MDEV Jun 2021 · PSIL Sep 2021)−10.2%−77.7%

About MDEV

By weight, 48% of MDEV's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 23% of the fund across 50 positions, as published by its issuer for Nov 12, 2026.

More

Over the year to Nov 13, 2026 the fund returned +8.8% with distributions reinvested. It sits 19.1% below its all-time high of Sep 7, 2021.

About PSIL

By weight, 8% of PSIL's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 69% of the fund across 27 positions, as filed for Jun 30, 2026.

More

Over the year to Nov 13, 2026 the fund returned +18.6% with distributions reinvested. It sits 78.3% below its all-time high of Sep 22, 2021.

0% of the two portfolios are the same securities at the same weight.

Questions people ask

Do MDEV and PSIL hold the same stocks?

By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, MDEV or PSIL?

MDEV has 48% of its weight in S&P 500 names and PSIL has 8%, so PSIL differs more from the index.

Which is cheaper, MDEV or PSIL?

MDEV charges 0.70% a year and PSIL charges 1.00%, so MDEV is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, MDEV against PSIL, data as of Nov 13, 2026. https://etfiq.com/compare/themes/mdev-vs-psil

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.